Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R S Neiman

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
American Journal of Clinical Pathology|July 1, 1991
The predictive value of bone marrow morphologic characteristics and immunostaining in primary (AL) amyloidosisS S Wu, K Brady, J J Anderson, et al.
American Journal of Clinical Pathology|June 30, 2000
Immunohistochemistry can be used to subtype acute myeloid leukemia in routinely processed bone marrow biopsy specimens. Comparison with flow cytometryE J Manaloor, R S Neiman, D K Heilman, et al.
The American Journal of Surgical Pathology|November 1, 1993
Primary hepatic B-cell lymphoma in a childM H Collins, A Orazi, M Bauman, et al.
Clinical and Diagnostic Laboratory Immunology|September 1, 1994
Comparison of corticosteroid- and L3T4+ antibody-immunosuppressed mouse models of Pneumocystis carinii pneumonia for evaluation of drugs and leukocytesM S Bartlett, W L Current, A Orazi, et al.
Human Pathology|April 1, 1992
Immunohistochemical localization of human immunodeficiency virus p24 antigen in placental tissueA W Martin, K Brady, S I Smith, et al.
Leukemia & Lymphoma|July 1, 1995
Aggressive chemotherapy in the treatment of Burkitt's and non-Burkitt's undifferentiated lymphomaJ J Mazza, J D Hines, J W Andersen, et al.
Cancer|May 1, 1988
Chemotherapy followed by consolidation radiation therapy for the treatment of clinical stage II aggressive histologic type non-Hodgkin's lymphomaM J O'Connell, D P Harrington, J D Earle, et al.
Leukemia & Lymphoma|June 28, 2001
Bleomycin, lomustine, cyclophosphamide, vincristine, procarbazine and prednisone (BLEO-CCVPP) in patients with Hodgkin's disease who relapsed after radiotherapy alone: a long-term follow-up study of the Eastern Cooperative Oncology Group (E3481)P H Wiernik, T Leong, M M Oken, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1991
Pentostatin induces durable remissions in hairy cell leukemiaP A Cassileth, B Cheuvart, A S Spiers, et al.
Cancer Treatment Reports|April 1, 1982
Treatment of advanced Hodgkin's disease: 10-year experience in the Eastern Cooperative Oncology groupJ H Glick, J M Barnes, R F Bakemeier, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
American Journal of Clinical Pathology|July 1, 1991
The predictive value of bone marrow morphologic characteristics and immunostaining in primary (AL) amyloidosisS S Wu, K Brady, J J Anderson, et al.
American Journal of Clinical Pathology|June 30, 2000
Immunohistochemistry can be used to subtype acute myeloid leukemia in routinely processed bone marrow biopsy specimens. Comparison with flow cytometryE J Manaloor, R S Neiman, D K Heilman, et al.
The American Journal of Surgical Pathology|November 1, 1993
Primary hepatic B-cell lymphoma in a childM H Collins, A Orazi, M Bauman, et al.
Clinical and Diagnostic Laboratory Immunology|September 1, 1994
Comparison of corticosteroid- and L3T4+ antibody-immunosuppressed mouse models of Pneumocystis carinii pneumonia for evaluation of drugs and leukocytesM S Bartlett, W L Current, A Orazi, et al.
Human Pathology|April 1, 1992
Immunohistochemical localization of human immunodeficiency virus p24 antigen in placental tissueA W Martin, K Brady, S I Smith, et al.
Leukemia & Lymphoma|July 1, 1995
Aggressive chemotherapy in the treatment of Burkitt's and non-Burkitt's undifferentiated lymphomaJ J Mazza, J D Hines, J W Andersen, et al.
Cancer|May 1, 1988
Chemotherapy followed by consolidation radiation therapy for the treatment of clinical stage II aggressive histologic type non-Hodgkin's lymphomaM J O'Connell, D P Harrington, J D Earle, et al.
Leukemia & Lymphoma|June 28, 2001
Bleomycin, lomustine, cyclophosphamide, vincristine, procarbazine and prednisone (BLEO-CCVPP) in patients with Hodgkin's disease who relapsed after radiotherapy alone: a long-term follow-up study of the Eastern Cooperative Oncology Group (E3481)P H Wiernik, T Leong, M M Oken, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1991
Pentostatin induces durable remissions in hairy cell leukemiaP A Cassileth, B Cheuvart, A S Spiers, et al.
Cancer Treatment Reports|April 1, 1982
Treatment of advanced Hodgkin's disease: 10-year experience in the Eastern Cooperative Oncology groupJ H Glick, J M Barnes, R F Bakemeier, et al.
Pageof 11